Imicrit 1000 mg/1000 mg Injection
Marketer
Cipla Ltd
Salt Composition
Imipenem (1000mg) + Cilastatin (1000mg)
Overview Imicrit 1000 mg/1000 mg Injection
Combiflox 1000 mg/1000 mg Injection is a dual-antibiotic formulation indicated for treating severe bacterial infections. This medication combats infectious microorganisms, thereby curbing infection progression. Administration of Combiflox 1000 mg/1000 mg Injection must be strictly under a physician's direct supervision. Adherence to the prescribed dosage schedule is crucial; complete the entire course of treatment, even with symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and skin rashes. Localized injection site reactions like redness, swelling, and pain are possible but typically resolve spontaneously. Escalating side effects necessitate immediate medical consultation. Seek emergency medical attention for allergic reactions such as rash, itching, swelling, or respiratory distress. Prior to commencing treatment, disclose all current medications and health conditions to your doctor. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, avoid driving if drowsiness or dizziness occurs.
Uses of Imicrit 1000 mg/1000 mg Injection
Life-threatening bacterial infections
Major Benefits of Imicrit 1000 mg/1000 mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Imicrit 1000 mg/1000 mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Imicrit 1000 mg/1000 mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Imicrit 1000 mg/1000 mg Injection works:
Imicrit 1000 mg/1000 mg Injection combines imipenem, an antibiotic, with cilastatin, a dehydropeptidase I inhibitor. Imipenem's antibacterial action disrupts bacterial cell wall synthesis, hindering their survival. Cilastatin protects imipenem from enzymatic degradation (by dehydropeptidase I), thereby extending its therapeutic efficacy within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imicrit 1000 mg/1000 mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Imicrit 1000 mg/1000 mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Imicrit 1000 mg/1000 mg Injection safely. Available human data indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Administration of Imicrit 1000 mg/1000 mg Injection can induce adverse reactions potentially impairing driving capabilities. Certain side effects, including hallucinations (visual, auditory, or sensory), may compromise driving safety for some individuals.
KidneyCAUTION
Renal impairment necessitates careful administration of Imicrit 1000 mg/1000 mg Injection. Dosage modification may be required. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Imicrit 1000 mg/1000 mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Imicrit 1000 mg/1000 mg Injection :
Should you forget a dose of Imicrit 1000 mg/1000 mg Injection, seek your physician's advice.
Facts to Know About Imicrit 1000 mg/1000 mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently